Phillips 66/ US7185461040 /
6/26/2024 10:10:00 PM | Chg. -0.46 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
139.78USD | -0.33% | 1.52 mill. Turnover: 136.69 mill. |
138.67Bid Size: 100 | 139.79Ask Size: 100 | 59.26 bill.USD | 3.00% | 8.98 |
GlobeNewswire
6/26
EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulat...
GlobeNewswire
6/25
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technolog...
GlobeNewswire
6/20
The International Food Information Council (IFIC) Releases Annual Food & Health Survey Revealing Ris...
GlobeNewswire
6/17
Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire
6/17
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
6/12
Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire
6/5
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
5/22
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
5/20
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire
5/16
Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire
5/16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
5/15
King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...